• 
  Katherine Marougka, Delphine Judith, Tristan Jaouen, Sabine Blouquit-Laye, Gina Cosentino, et al.. Antagonism of BST2/Tetherin, a new restriction factor of respiratory syncytial virus, requires the viral NS1 protein. PLoS Pathogens, 2024, 20 (11), pp.e1012687. ⟨10.1371/journal.ppat.1012687⟩. ⟨hal-04831685⟩
• 
  Adriana Traore, Kelly Charniga, Sophie Grellet, Garance Terpant, Héléna da Cruz, et al.. Monitoring SARS-CoV-2 variants with complementary surveillance systems: risk evaluation of the Omicron JN.1 variant in France, August 2023 to January 2024. Eurosurveillance, 2025, 30 (1), pp.1192-1194. ⟨10.2807/1560-7917.ES.2025.30.1.2400293⟩. ⟨hal-04895964⟩
• 
  Lore Merdrignac, Charlotte Laniece Delaunay, Nuno Verdasca, Lorena Vega-Piris, Joan O Donnell, et al.. Effectiveness of XBB.1.5 Vaccines Against Symptomatic SARS-CoV-2 Infection in Older Adults During the JN.1 Lineage-Predominant Period, European VEBIS Primary Care Multicentre Study, 20 November 2023u20131 March 2024. Influenza and Other Respiratory Viruses, 2024, 18 (11), ⟨10.1111/irv.70009⟩. ⟨hal-04831667⟩
• 
  Thomas Bazin, Karine Nozeret, Catherine Julié, Dominique Lamarque, Eliette Touati. Protein Biomarkers of Gastric Preneoplasia and Cancer Lesions in Blood: A Comprehensive Review. Cancers, 2024, 16 (17), ⟨10.3390/cancers16173019⟩. ⟨hal-04831586⟩
• 
  Bérangère S. Joly, Agnès Veyradier, Paul Coppo, Adrien Joseph, Claire Dossier, et al.. Management of congenital thrombotic thrombocytopenic purpura in the era of recombinant ADAMTS13 protein: Recommendations from the Reference Center for Thrombotic Microangiopathies (CNR-MAT). La Revue de Médecine Interne, 2024, ⟨10.1016/j.revmed.2024.11.004⟩. ⟨hal-04831735⟩

427

277